2.1. Study design and sample:
A cohort random study with a probabilistic sampling design of Congolese participants with and without oral cancer was conducted in the Department of Oral and Maxillofacial Surgery, Hospital of Kinshasa University, and that of H Plamed Clinical Center of the National Center Laboratory of Oral Biomedicine, Ministry of Research Innovation and Technology, DR. Congo from 2020 to 2023. All procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the Ethics Committee of the above National Center Laboratory (CNRSBD1504.217). Written informed consent was obtained from all participants before study participation.
2.2. Participants recruitment
A total of 1012 participants were invited to participate in the study. Of these, 827 agreed to participate (adhesion rate = 82 %). Patients with OC diagnosed histologically, treated at the same hospital, from which biological material was biopsied during surgery and stored, were included. Those participants who completed all items for the clinical questionnaire and measuring instruments (OHIP-14), with cognitive ability, and capacity to answer the OHIP-14 questionnaires were also included. Exclusion criteria were benign tumors or OC diagnosed at another hospital without detailed information. Participants with joint diseases (n=57), with psychiatric disturbance (n=6), data records without any detail for review (n=54), refused to participate in the study (n=37) and OC treated at other hospitals without evidence of histopathologic result (n=31) were excluded. After this applying exclusion criteria and providing informed consent, 827 participants were included in the study. They were randomly assigned into 2 groups for evaluating the quality of life. One group of patients with oral cancer (OCP group, n=459) than the healthy participant group (control group, n=368). Eligibility criteria for the control group included no psychiatric disturbance and no intellectual disability. The exclusion criteria were inability to meet the above requirements and refusal to participate in the study. To OCP group was assigned into two sub-groups to compare the quality of life between the group patients received the treatment (n=240) than those did not (n=219) (flow chart: figure 1).
2.3. Data collection and measurement
Participants were interviewed by well-trained doctors of Master's degree, using interview-administered questionnaires. The questionnaire was developed through an iterative collaborative process, among public health experts and researchers at the National Center Laboratory of Oral Biomedicine. The study questionnaire was piloted before the launch of the study and adjusted accordingly. The additional information was obtained from the patient’s medical records in the Pathology Department and from the computed tomography scan. The Oral Health-related Quality of Life (OHRQoL), was evaluated through the Persian version of the valid questionnaire OHIP‑14 .( Koocheki et al. 2019) The interviews were presential and the investigators read the questions to the patients for those were illiterate and the answers were applied themselves. The questionnaires were prepared in the French language and helped to conduct a face-to-face pilot interview with 17 patients. After a normality pretest, data were analyzed using Kolmogorov–Smirnov, Cronbach's α correlation coefficient, P > 0.05, indicating that the survey had normal distribution data. The results of the pilot study were not included in the present research. The questionnaire consists of 14 questions analyzed seven aspects of quality of life including functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap. The 5-point Likert scale was used (Score 0 =means never, 1= rarely, 2 =occasionally, 3 =often, and 4 =always). ( Llewellyn et al. 2003) And finally, the overall OHRQoL per participant was represented by the sum of the outcomes of the individual questions. A higher score shows a lower OHRQoL.
2.4. Treatments
All forms of cancer treatment were considered including surgery, radiotherapy, chemotherapy, observation, traditional medicine, and palliation therapy, defined as supportive care and pain management.
2.5. Study variables
The study variables were age, gender, marital status, religion, occupation, education level, delays or not of the initial treatment, health information challenges, side-effects of cancer treatment, functional limitations, psychological discomfort, physical inability, and physical pain that were evaluated.
2.6. Statistical Analysis
Data was analyzed with SPSS software version 24 IBM Corporation, New York, USA. The Chi‑square test was used to compare the percentage of qualitatively dependent variables among the groups, independent sample t‑test to compare OHIP score for variables in two groups, and one‑way ANOVA for variables in more than two groups. Finally, a linear regression in three models to evaluate the mean OHIP score was used. Statistical significance was set at 5%.